RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
74 hedge funds and large institutions have $1.01B invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
76% more capital invested
Capital invested by funds: $573M → $1.01B (+$434M)
45% more funds holding
Funds holding: 51 → 74 (+23)
Holders
74
Holding in Top 10
4
Calls
$7.38M
Puts
$67K
Top Buyers
| 1 | +$48.3M | |
| 2 | +$25.7M | |
| 3 | +$9.65M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$8.44M |
| 5 |
FAM
Fred Alger Management
New York
|
+$6.82M |
Top Sellers
| 1 | -$43.9M | |
| 2 | -$23.8M | |
| 3 | -$11.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.23M |
| 5 |
PA
Perceptive Advisors
New York
|
-$5.58M |